Anders Hammerich Riis
Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010 Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
To evaluate the impact of risk minimisation policies on the use of rosiglitazone-containing products and on glycaemic control among patients in Denmark and the UK.
Original language English Journal BMJ Open Volume 3 Issue 9 Pages (from-to) e003424 ISSN 2044-6055 DOIs Publication status Published - 2013
See relations at Aarhus University Citationformats
ID: 56880529
Department of
Aarhus University Hospital
Contact
Phone: +45 87 16 72 12
